Appendix 4D Half Year Ended 31 December 2013
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Westcoast Expands To East Coast
- Half Yearly Report and Accounts (including Appendix 4D)
- SUDA receives $0.7m R&D tax incentive refund
- Westcoast Surgical & Medical Supplies Update
- Westcoast Launches Novel Hemostyp Gauze
Later from Arovella Therapeutics
- SUDA Signs Option To Acquire NovaMist Technology
- ArTiMist Update
- Clinical Trial Update May 2011
- Eastland Update
- Manufacturing update
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics